Rajindera Lithotripsy Profile
Key Indicators
- Authorised Capital ₹ 3.50 M
- Paid Up Capital ₹ 2.40 M
- Company Age 28 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.00 M
- Revenue Growth -73.68%
- Profit Growth -181.60%
- Ebitda -391.01%
- Net Worth -1.87%
- Total Assets 2.04%
About Rajindera Lithotripsy
Rajindera Lithotripsy Private Limited (RLPL) is a Private Limited Indian Non-Government Company incorporated in India on 09 September 1996 and has a history of 28 years and four months. Its registered office is in Delhi, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.50 M and a paid-up capital of Rs 2.40 M.
The company currently has active open charges totaling ₹1.00 M.
Hukam Singh and Rajinder Yadav serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U85120DL1996PTC081748
- Company No.
081748
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Sep 1996
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Rajindera Lithotripsy?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajinder Yadav  | Director | 19-Sep-1996 | Current |
| Hukam Singh | Director | 13-May-1998 | Current |
Financial Performance of Rajindera Lithotripsy.
Rajindera Lithotripsy Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 73.68% decrease. The company also saw a substantial fall in profitability, with a 181.6% decrease in profit. The company's net worth dipped by a decrease of 1.87%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rajindera Lithotripsy?
In 2020, Rajindera Lithotripsy had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹1.00 M
₹0
Charges Breakdown by Lending Institutions
- Bank Of India : 0.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Nov 1996 | Bank Of India | ₹1.00 M | Open |
How Many Employees Work at Rajindera Lithotripsy?
Unlock and access historical data on people associated with Rajindera Lithotripsy, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rajindera Lithotripsy, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rajindera Lithotripsy's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.